Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.28
+0.19 (0.90%)
At close: Nov 22, 2024, 4:00 PM
21.40
+0.12 (0.56%)
After-hours: Nov 22, 2024, 5:59 PM EST
KNSA Employees
Kiniksa Pharmaceuticals International, had 297 employees as of December 31, 2023. The number of employees increased by 77 or 35.00% compared to the previous year.
Employees
297
Change (1Y)
77
Growth (1Y)
35.00%
Revenue / Employee
$1,293,259
Profits / Employee
-$30,532
Market Cap
1.54B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| U.S. Physical Therapy | 6,720 |
| Schrödinger | 867 |
| Alphatec Holdings | 839 |
| InMode | 581 |
| BioCryst Pharmaceuticals | 536 |
| Intellia Therapeutics | 526 |
| Harrow | 315 |
| Nurix Therapeutics | 284 |
KNSA News
- 10 days ago - Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 24 days ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 4 weeks ago - Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024 - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat - Seeking Alpha
- 4 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire